1. Home
  2. LEGN vs ABCB Comparison

LEGN vs ABCB Comparison

Compare LEGN & ABCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • ABCB
  • Stock Information
  • Founded
  • LEGN 2014
  • ABCB 1971
  • Country
  • LEGN United States
  • ABCB United States
  • Employees
  • LEGN N/A
  • ABCB N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • ABCB Major Banks
  • Sector
  • LEGN Health Care
  • ABCB Finance
  • Exchange
  • LEGN Nasdaq
  • ABCB Nasdaq
  • Market Cap
  • LEGN 5.4B
  • ABCB 4.4B
  • IPO Year
  • LEGN 2020
  • ABCB N/A
  • Fundamental
  • Price
  • LEGN $38.96
  • ABCB $67.53
  • Analyst Decision
  • LEGN Strong Buy
  • ABCB Buy
  • Analyst Count
  • LEGN 12
  • ABCB 6
  • Target Price
  • LEGN $73.91
  • ABCB $69.83
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • ABCB 354.1K
  • Earning Date
  • LEGN 08-08-2025
  • ABCB 07-28-2025
  • Dividend Yield
  • LEGN N/A
  • ABCB 1.19%
  • EPS Growth
  • LEGN N/A
  • ABCB 31.20
  • EPS
  • LEGN N/A
  • ABCB 5.38
  • Revenue
  • LEGN $728,303,000.00
  • ABCB $1,100,260,000.00
  • Revenue This Year
  • LEGN $65.49
  • ABCB $12.06
  • Revenue Next Year
  • LEGN $53.76
  • ABCB $6.18
  • P/E Ratio
  • LEGN N/A
  • ABCB $12.55
  • Revenue Growth
  • LEGN 112.46
  • ABCB 13.98
  • 52 Week Low
  • LEGN $27.34
  • ABCB $48.27
  • 52 Week High
  • LEGN $60.87
  • ABCB $74.56
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 66.26
  • ABCB 70.26
  • Support Level
  • LEGN $34.64
  • ABCB $66.92
  • Resistance Level
  • LEGN $39.88
  • ABCB $68.10
  • Average True Range (ATR)
  • LEGN 1.46
  • ABCB 1.32
  • MACD
  • LEGN 0.37
  • ABCB 0.25
  • Stochastic Oscillator
  • LEGN 87.67
  • ABCB 87.34

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About ABCB Ameris Bancorp

Ameris Bancorp is a bank holding company that operates through Ameris Bank, its subsidiary. The company operates branches in Georgia, Alabama, Florida, and South Carolina. It offers traditional banking services such as business banking, personal banking, checking, savings, mobile banking, and others. The bank is organized into four segments: the Banking Division, the Retail Mortgage Division, the Warehouse Lending Division and the Premium Finance Division. The company generates majority of its revenue from the banking division. Ameris intends to acquire banks in its geographic region to increase its market share and expand beyond its current market.

Share on Social Networks: